Earnings Call · Q1 FY2022·2022-05-04

Q1 22EPS +48.08%·Rev n/aQ4 21EPS +100.00%*·Rev n/aQ3 21EPS -6.25%·Rev n/aQ2 21EPS +18.75%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

Unidentified Company Representative — Investor Relations or Corporate Communications

Brett Monia — Chief Executive Officer

Elizabeth Hougen — Chief Financial Officer

Eugene Schneider — Chief Medical Officer

+2.8%1d on move date−0.2% vs SPY3d−5.7%5d−11.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access